Mots-C Peptide Therapy
Mots-C is a mitochondrial-derived peptide encoded in the mitochondrial genome. Researched for metabolic regulation, insulin sensitivity, and exercise capacity.
/)
/)
What Mots-C may support
Mots-C declines with age and is implicated in mitochondrial signaling, insulin sensitivity, and metabolic flexibility. Researched in age-related metabolic decline and exercise capacity contexts.
Our team uses Mots-C in metabolic and longevity-oriented protocols, typically alongside lifestyle assessment, with conservative dosing given the emerging evidence base.
Patient experiences
Metabolic markers had been creeping for years. The doctor scoped Mots-C as part of a broader plan, not as a one-shot fix.
Wanted to support exercise capacity without TRT. Mots-C felt like the right starting point. Twelve-week cycle.
Doctor was honest that the evidence is emerging. We approached it conservatively and tracked specific markers.
Our solutions for Weight‑Loss Management
What BPC-157 is studied for
Indications evaluated in research, listed in order of current evidence weight. Suitability is determined case-by-case.
/)
What is Mots-C?
Mots-C is a mitochondrial-derived peptide encoded in the mitochondrial genome. Researched for metabolic regulation, insulin sensitivity, and exercise capacity.
/)
How Mots-C may work
Mots-C is encoded in mitochondrial DNA and acts on mitochondrial signaling, AMPK pathways, and insulin sensitivity. The mechanism is upstream of most other therapeutic peptides.
/)
Who it may be evaluated for
Adults over 40 with metabolic decline or exercise-capacity concerns, particularly when conventional approaches aren't moving labs. Conservative dosing, emerging evidence base.
/)
How Menscape prescribes Mots-C
12 to 16 week protocol with daily or several-times-weekly subcutaneous injection. Baseline and post-protocol metabolic markers tracked.
Doctor-led evaluation
Every Mots-C protocol starts with a full medical consultation and history review.
Licensed compounding pharmacy
Prescriptions are filled by a licensed compounding pharmacy partner, not over-the-counter.
Monthly monitoring
Follow-up consultations every four to six weeks to assess response and safety.
Research-informed positioning
We frame Mots-C as a research-stage peptide and prescribe only when clinically appropriate.
Mots-C questions
How is Mots-C different from other peptides?
Mots-C is encoded in mitochondrial DNA (not nuclear DNA) and acts on mitochondrial signaling specifically. Most other therapeutic peptides act on cell-surface receptors.
Is Mots-C FDA-approved?
No. Mots-C is an emerging research peptide. Use is off-label and doctor-supervised.
Who is Mots-C suitable for?
Most-studied in adults over 40 with metabolic or exercise-capacity concerns. Doctor assesses suitability based on labs and goals.
Are results immediate?
No. Metabolic and mitochondrial changes take weeks to months. Protocols are typically 12 to 16 weeks with follow-up labs.
What lab tests do you run before starting?
Baseline fasting glucose, HbA1c, lipid panel, and a metabolic-flexibility marker set (typically including insulin and inflammatory markers). We re-test at the end of the 12 to 16 week protocol.
When will I notice changes?
Metabolic markers and exercise-capacity changes are gradual and most visible from week 6 to 8 onwards. Subjective improvements in energy and recovery are sometimes earlier.
Talk with our medical team about BPC-157
/)